EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

miR-101-3p suppresses proliferation of orbital fibroblasts by targeting pentraxin-3 in thyroid eye disease

Yanfei Zhu, Yuqing Chen, Xingyi Shu, Ruili Wei

PeerJ · 2024

DOI: 10.7717/peerj.18535 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, 2024. Verfasst von Yanfei Zhu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Changzheng Hospital of Naval Medical University, Shanghai, China. Hauptthemen laut MEDLINE: MicroRNAs, Graves Ophthalmopathy, Fibroblasts, Cell Proliferation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Excessive proliferation of orbital fibroblasts (OFs) is an essential factor in the pathogenesis of thyroid eye disease (TED). While existing evidence indicates that various microRNAs (miRNAs) significantly contribute to TED development, the precise function and targets of miR-101-3p in TED pathogenesis remain unknown. This research aims to elucidate the effects of miR-101-3p on TED-OFs and identify its potential targets.

Methods

Orbital adipose tissues were harvested from both TED patients and healthy controls to culture their fibroblasts. MiR-101-3p mimic or mimic negative control (mimic NC) was transfected into OFs from TED patients, with untreated OFs serving as an additional blank control group. Cell proliferation was assessed using cell counting kit-8 (CCK-8) assay, Ki-67 immunofluorescence staining, and the EdU assay, while apoptosis was evaluated via flow cytometry. Quantitative real-time polymerase chain reaction (qRT-PCR) was employed to measure the expression levels of miR-101-3p and pentraxin-3 (PTX3), and PTX3 protein levels were quantified using western blot. A dual-luciferase assay was conducted to ascertain how miR-101-3p and PTX3 interacted.

Results

The results demonstrated a significant downregulation of miR-101-3p in fibroblasts and TED orbital adipose tissues. Transfection with the miR-101-3p mimic upregulated miR-101-3p levels, significantly reducing OFs proliferation without affecting apoptosis. Overexpression of miR-101-3p led to the downregulation of PTX3 in OFs. The dual-luciferase assay validated miR-101-3p binding to PTX3’s 3’UTR, thereby repressing its expression. Moreover, overexpression of PTX3 partially rescued the miR-101-3p mimic’s inhibitory effect on TED-OFs proliferation.

Conclusion

Our findings illustrate miR-101-3p’s role in targeting PTX3 to regulate TED-OFs proliferation, providing novel insights into the pathological mechanisms underlying TED development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsGraves OphthalmopathyFibroblastsCell ProliferationSerum Amyloid P-ComponentC-Reactive ProteinHumansApoptosisMaleFemaleOrbitCells, CulturedMiddle AgedAdultCase-Control StudiesPentraxins

Stichwörter der Autor:innen

ApoptosisMiR-101-3pOrbital fibroblastsPentraxin-3ProliferationThyroid eye disease

Substanzen

MicroRNAsSerum Amyloid P-ComponentC-Reactive ProteinPentraxinsMIRN101 microRNA, human

Autor:innen und Institutionen

  • Department of Ophthalmology, Changzheng Hospital of Naval Medical University, Shanghai, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhu, Y., Chen, Y., Shu, X., & Wei, R. (2024). miR-101-3p suppresses proliferation of orbital fibroblasts by targeting pentraxin-3 in thyroid eye disease. PeerJ. https://doi.org/10.7717/peerj.18535

Vancouver

Zhu Y, Chen Y, Shu X, Wei R. miR-101-3p suppresses proliferation of orbital fibroblasts by targeting pentraxin-3 in thyroid eye disease. PeerJ. 2024. doi:10.7717/peerj.18535

BibTeX
@article{Zhu2024,
  author = {Zhu, Yanfei and Chen, Yuqing and Shu, Xingyi and Wei, Ruili},
  title = {miR-101-3p suppresses proliferation of orbital fibroblasts by targeting pentraxin-3 in thyroid eye disease},
  journal = {PeerJ},
  year = {2024},
  doi = {10.7717/peerj.18535}
}
Kostenlos starten →